Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Impact of Social Determinants of Health and Geographic Location on Real-World Outcomes in AML Patients Undergoing Low-Intensity Chemotherapy

Valerie Tran, Gordon Smilnak, Nandan Srinivasa, Firas El Chaer, Michael Keng, Daniel Reed

Blood (2024) 144 (Supplement 1): 7904.

https://doi.org/10.1182/blood-2024-201720

Published: 2024

Journal Articles

Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)

Blood (2024) 144 (Supplement 1): 736.

https://doi.org/10.1182/blood-2024-210370

Published: 2024

Journal Articles

Quality Improvement Initiative of Patients with Acute Myeloid Leukemia Receiving Non-Intensive Therapy in Academic-Community Medicine Partnerships in Rural Appalachia

Natalie Pham, Jeffrey Lantz, Jr., Caroline Jones, Debamita Kundu, Nicholas McCann, Firas El Chaer, Daniel Reed, Michael Keng

Blood (2024) 144 (Supplement 1): 791.

https://doi.org/10.1182/blood-2024-211962

Published: 2024

Journal Articles

Treatment Outcomes with Hypomethylating Agents and Venetoclax for AML in the Community Compared to an Academic Setting

Jeffrey Lantz, Jr., Natalie Pham, Caroline Jones, Debamita Kundu, Nicholas McCann, Firas El Chaer, Daniel Reed, Michael Keng

Blood (2023) 142 (Supplement 1): 7436.

https://doi.org/10.1182/blood-2023-190176

Published: 2023